- Home
- VMAR vs THAR Comparison
VMAR vs THAR Comparison
Compare VMAR & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMAR
- THAR
- Stock Information
- Founded
- VMAR 1995
- THAR 2017
- Country
- VMAR Canada
- THAR United States
- Employees
- VMAR N/A
- THAR N/A
- Industry
- VMAR Marine Transportation
- THAR Biotechnology: Pharmaceutical Preparations
- Sector
- VMAR Industrials
- THAR Health Care
- Exchange
- VMAR Nasdaq
- THAR Nasdaq
- Market Cap
- VMAR 5.1M
- THAR 5.5M
- IPO Year
- VMAR 2020
- THAR 2022
- Fundamental
- Price
- VMAR $6.60
- THAR $1.49
- Analyst Decision
- VMAR Strong Buy
- THAR Strong Buy
- Analyst Count
- VMAR 1
- THAR 1
- Target Price
- VMAR $2,700.00
- THAR $17.00
- AVG Volume (30 Days)
- VMAR 39.6K
- THAR 45.3K
- Earning Date
- VMAR 07-11-2025
- THAR 08-08-2025
- Dividend Yield
- VMAR N/A
- THAR N/A
- EPS Growth
- VMAR N/A
- THAR N/A
- EPS
- VMAR N/A
- THAR N/A
- Revenue
- VMAR $1,128,568.00
- THAR N/A
- Revenue This Year
- VMAR N/A
- THAR N/A
- Revenue Next Year
- VMAR $264.29
- THAR N/A
- P/E Ratio
- VMAR N/A
- THAR N/A
- Revenue Growth
- VMAR N/A
- THAR N/A
- 52 Week Low
- VMAR $4.04
- THAR $0.95
- 52 Week High
- VMAR $675.00
- THAR $6.39
- Technical
- Relative Strength Index (RSI)
- VMAR 48.62
- THAR 41.17
- Support Level
- VMAR $5.74
- THAR $1.60
- Resistance Level
- VMAR $6.28
- THAR $1.75
- Average True Range (ATR)
- VMAR 0.34
- THAR 0.11
- MACD
- VMAR 0.06
- THAR -0.03
- Stochastic Oscillator
- VMAR 68.98
- THAR 0.00
About VMAR Vision Marine Technologies Inc.
Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.